Skip to main content

Advertisement

Log in

All-trans retinoic acid induces apoptosis in acute myeloblastic leukaemia cells

  • Published:
Apoptosis Aims and scope Submit manuscript

Abstract

The effect of all-trans retinoic acid (ATRA) on leukaemia cell differentiation, proliferation and induction of apoptosis was studied by using autonomously growing blast cells isolated from eight patients with acute myeloblastic leukaemia (AML) either at diagnosis ( n=4) or at relapse (n=4). No morphological or functional differentiation induced by ATRA was observed in any of the cases studied. In cell cultures, inhibition of leukaemia cell growth by ATRA was obvious, especially in the case of clonogenic cells, and it was both time- and concentration-dependent. Induction of apoptosis was more difficult to achieve. The cells retained over 90% viability in suspension when the ATRA exposure at any of the concentrations studied was 48 h or less. When the time of exposure to ATRA was longer than 48 h, the viability of the cells decreased in a concentration-dependent manner. Apoptosis was observed morphologically in each of the AML cases with 10-5 to 10-8 M ATRA, if the incubation time of cells in ATRA was 72 h. The percentage of apoptotic cells increased with increasing ATRA concentrations from 12± 9% of 10-8 M ATRA to 78±12% of 10-5 M ATRA. The DNA electrophoretic method was able to detect apoptosis in all the AML samples exposed to 10-7 and 10-6 ATRA for 48 h and occasionally in cases where lower concentrations and longer exposure time were used. In conclusion, the present study shows that it is possible to induce apoptotic leukaemia cell death in vitro with ATRA in AML, and this effect is dependent on both concentration and exposure time.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Douer D, Koeffler P. Retinoic acid enhances colony-stimulating factor-induced clonal growth of normal human myeloid progenitor cells in vitro. Exp Cell Res 1982; 138: 193-198.

    Google Scholar 

  2. Nilsson B, Olofson T, Olsson I. Myeloid differentiation in liquid cultures of cells from patients with chronic myeloid leukemia: effects of retinoic acid and indomethacin. Exp Hematol 1985; 13: 1094-1100.

    Google Scholar 

  3. Sakashita A, Kizaki M, Pakkala S, et al. 9-cis retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood 1993; 81: 1009-1016.

    Google Scholar 

  4. van Boeckstaele DR, Lenjou M, Snoeck H-WW, Lardon F, Stryckmans P, Peetermans ME. Direct effects of 13-cis and all-trans retinoic acid on normal bone marrow (BM) progenitors: comparative study on BM mononuclear cells and on isolated CD34+ BM cells. Ann Hematol 1993; 66: 61-66.

    Google Scholar 

  5. Gratas C, Menot ML, Dresch C, Chomienne C. Retinoic acid supports granulocytic but not erythroid differentiation of myeloid progenitors in normal bone marrow cells. Leukemia 1993; 7: 1156-1162.

    Google Scholar 

  6. Tsai S, Collins SJ. A dominant negative retinoic acid receptor blocks neutrophil differentiation at the promyelocyte stage. Proc Natl Acad Sci USA 1993; 90: 7153-7157.

    Google Scholar 

  7. Bradley EC, Ruscetti FW, Steinberg H, Paradise C, Blaine K. Inhibition of differentiation and proliferation of colony-stimulating factor-induced clonal growth of normal human marrow cells in vitro by retinoic acid. JNCI 1983; 71: 1189-1192.

    Google Scholar 

  8. Januszewicz E, Cooper IA. Inhibition of normal human macrophage progenitors by retinoic acid. Br J Haematol 1984; 58: 119-128.

    Google Scholar 

  9. Breitman TR, Selonick SE, Collins SJ. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc Natl Acad Sci USA 1980; 77: 2936-2940.

    Google Scholar 

  10. Breitman TR, Collins SJ, Kneene BR. Terminal differentiation of human promyelocytic leukemic cells in primary culture in response to retinoic acid. Blood 1981; 57: 1000-1004.

    Google Scholar 

  11. Chen Z-X, Xue Y-Q, Tao R-F, et al. A clinical and experimental study on all-trans retinoic acid-treated acute promyelocytic leukemia patients. Blood 1991; 78: 1413-1419.

    Google Scholar 

  12. Lawrence JH, Conner K, Kelly MA, Haussler MR, Wallace P, Bagby GC Jr. Cis-retinoic acid stimulates the clonal growth of some myeloid leukemia cells in vitro. Blood 1987; 69: 302-307.

    Google Scholar 

  13. Largman C, Detmer K, Corral JC, Hack FM, Lawrence HJ. Expression of retinoic acid receptor gene in myeloid leukemia cells. Leukemia 1989; 3: 264-269.

    Google Scholar 

  14. Chomienne C, Ballerini P, Balitrand N, et al. All-trans retinoic acid in acute promyelocytic leukemias. II In vitro studies: structure-function relationship. Blood 1990; 76: 1710-1717.

    Google Scholar 

  15. Douer D, Koeffler P. Retinoic acid. Inhibition of the clonal growth of human myeloid leukemia cells. J Clin Invest 1982; 69: 277-283.

    Google Scholar 

  16. Wang C, Curtis JE, Minden MD, McCulloch EA. Expression of retinoic acid receptor gene in myeloid leukemia cells. Leukemia 1989; 3: 264-269.

    Google Scholar 

  17. Koistinen P, Wang C, Yang G-S, et al. OCI/AML-4 an acute myeloblastic leukemia cell line: regulation and response to cytosine arabinoside. Leukemia 1991; 5: 704-711.

    Google Scholar 

  18. Tohda S, Curtis JE, McCulloch EA, Minden M. Comparison of the effects of all-trans and cis-retinoic acid on the blast stem cells of acute myeloblastic leukemia in culture. Leukemia 1992; 6: 656-661.

    Google Scholar 

  19. Lishner M, Curtis CE, Minkin S, McCulloch EA. Interaction between retinoic acid and cytosine arabinoside affecting the blast cells of acute myeloblastic leukemia. Leukemia 1989; 3: 784-788.

    Google Scholar 

  20. Yang GS, Minden MD, McCulloch EA. Regulation by retinoic acid and hydrocortisone of the anthracycline sensitivity of blast cells of acute myeloblastic leukemia. Leukemia 1994; 8: 2065-2075.

    Google Scholar 

  21. Huang M-E, Ye Y-C, Chen S-R, et al. Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia. Blood 1988; 72: 567-572.

    Google Scholar 

  22. Castaigne S, Chomienne C, Daniel MT, et al. All-trans retinoic acid as a differentiation therapy for acute promyelocytic leukemia. I Clinical results. Blood 1990; 76: 1704-1709.

    Google Scholar 

  23. Fenaux P, Le Deley MC, Castaigne S, et al. Effect of all-trans retinoic acid in newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993; 82: 3241-3249.

    Google Scholar 

  24. Kramer ZB, Boros L, Wiernik PH, et al. 13-cis retinoic acid in the treatment of elderly patients with acute myeloid leukemia. A phase II pilot study of the Eastern Co-operatice Oncology Group. Cancer 1991; 67: 1484-1486.

    Google Scholar 

  25. Venditti A, Stasi R, Del Poeta G, et al. All-trans retinoic acid and low-dose cytosine arabinoside for the treatment of poor prognosis acute myeloid leukemia. Leukemia 1995; 9: 1121-1125.

    Google Scholar 

  26. Skrede B, Lie SO, Blomhoff R, Norum KR. Uptake and storage of retinol and retinyl esters in bone marrow of children with acute myeloid leukemia treated with high-dose retinyl palmitate. Eur J Haematol 1994; 52: 140-144.

    Google Scholar 

  27. Helmberg A, Auphan N, Caelles C, Karin M. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14: 452-460.

    Google Scholar 

  28. Maeda Y, Miyatake J, Sono H, et al. 13-cis retinoic acid inhibits growth of adult T cell leukemia cells and causes apoptosis; possible new indication for retinoid therapy. Int Med 1996; 35: 180-184.

    Google Scholar 

  29. Kalemkerian GP, Slusher R, Ramalingam S, Gadgeel S, Mabry M. Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines. JNCI 1995; 87: 1674-1680.

    Google Scholar 

  30. Shao ZM, Dawson MI, Li XS, et al. p53 independent G0/G1 arrest and apoptosis induced by a novel retinoid in human breast cancer cells. Oncogene 1996; 11: 493-504.

    Google Scholar 

  31. Liu Y, Lee M-O, Wang H-G, Li Y, et al. Retinoic acid receptor β mediates the growth-inhibitory effect of retinoic acid by promoting apoptosis in human breast cancer cells. Mol Cell Biol 1996; 16: 1138-1149.

    Google Scholar 

  32. Martin SJ, Bradley JG, Cotter TG. HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin Exper Immunol 1990; 79: 448-453.

    Google Scholar 

  33. Delia D, Aiello A, Lombardi L, et al. N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hematopoietic cell lines including those unresponsive to retinoic acid. Cancer Res 1993; 53: 6036-6041.

    Google Scholar 

  34. Nagy L, Thomazy VA, Shipley GL, et al. Activation of retinoic X receptors induces apoptosis in HL-60 cell lines. Mol Cell Biol 1995; 15: 3540-3551.

    Google Scholar 

  35. Park JR, Robertson K, Hickstein DD, Tsai S, Hockenberry DM, Collins SJ. Dysregulated bcl-2 expression inhibits apoptosis but not differentiation of retinoic acid-induced HL-60 granulocytes. Blood 1995; 84: 440-445.

    Google Scholar 

  36. Bruel A, Benoit G, De Nay D, Brown S, Lanotte M. Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and bcl-2 expression. Leukemia 1995; 9: 1173-1184.

    Google Scholar 

  37. Bennett JM, Catovsky D, Daniel MT, et al. Proposals for the classification of acute leukemias. Br J Haematol 1976; 33: 451-458.

    Google Scholar 

  38. Elonen E for the Finnish Leukemia Group. Intensive chemotherapy of adult acute myelogenous leukemia: a randomized trial between 4 and 8 cycles. Blood 1993; 82(Suppl 1): 328a.

    Google Scholar 

  39. Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21(Suppl 97): 77-89.

    Google Scholar 

  40. Buick RN, Till JE, McCulloch EA. Colony assay for proliferative blast cells circulating in myeloblastic leukemia. Lancet 1977; i: 862-863.

    Google Scholar 

  41. Nara N, McCulloch EA. The proliferation in suspension of the progenitors of the blast cells in acute myeloblastic leukemia. Blood 1985; 65: 1484-1493.

    Google Scholar 

  42. Tilly JL, Hsueh AJW. Microscale autoradiographic method for qualitative and quantitative analysis of apoptotic DNA fragmentation. J Cell Physiol 1993; 154: 519-526.

    Google Scholar 

  43. Gross-Bellard M, Oudet P, Chambon P. Isolation of high-molecular-weight DNA from mammalian cells. Eur J Biochem 1973; 36: 32-38.

    Google Scholar 

  44. Chomienne C, Balitrand N, Cost H, Degos L, Abita JP. Structure-activity relationship of aromatic retinoids on the differentiation of the human histiocytic lymphoma cell line U-937. Leuk Res 1986; 10: 1301-1305.

    Google Scholar 

  45. Lotan R. Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cells. Biochim Biophys Acta 1980; 605: 33-91.

    Google Scholar 

  46. Gillis JC, Goa KL. Tretinoin. A review of its pharmacodynamic and pharmacokinetic properties and use in the management of acute promyelocytic leukemia. Drugs 1995; 50: 897-923.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zheng, A., Savolainen, ER. & Koistinen, P. All-trans retinoic acid induces apoptosis in acute myeloblastic leukaemia cells. Apoptosis 2, 319–329 (1997). https://doi.org/10.1023/A:1026445321935

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1026445321935

Navigation